CollPlant Biotechnologies Ltd (CLGN)

15.68 -1.77  -10.14% NASDAQ Dec 3, 16:00 15.82 +0.14  +0.86% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All CLGN News

News

View All Events

Events

Date Type Description
03/25/2022 Earnings Results Q4 2021 Earnings Results
11/18/2021 Earnings Results Q3 2021 Earnings Results
08/19/2021 Earnings Results Q2 2021 Earnings Results
05/27/2021 Earnings Results Q1 2021 Earnings Results
03/26/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.
  • URL: https://www.collplant.com
  • Investor Relations URL: https://ir.collplant.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Mar. 25, 2022
  • Last Earnings Release: Nov. 18, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.